Glucose Gladiators Diabetes ERG at Glooko

At Glooko, we believe that people living with diabetes are the ultimate experts in their own care. This driving principle is the heartbeat of our mission and is deeply woven into our company culture. Nowhere is this more evident than in our diabetes-focused employee resource group (ERG), the Glucose Gladiators. They ensure we live our mission daily by putting the voice of the user at the center of innovation, driving us to improve diabetes care.

Embedding Real-World Diabetes Perspectives into Glooko

Recognizing the critical need to embed real-world experience into our work, a group of employees living with diabetes came together to found the Glucose Gladiators, a vibrant internal community dedicated to connection and support. The ERG is remarkably diverse, including people with Type 1 and 2 diabetes, caregivers, former nurses and healthcare providers, and women who experienced gestational diabetes. Their firsthand perspectives are our greatest asset. By sharing their personal experiences, Glooko is better equipped as a company to create a diabetes management solution that truly resonates and fulfills our core mission.

The ERG’s purpose is to:

  • Educate other employees at Glooko about the realities of life with diabetes.
  • Foster cross-department collaboration that drives meaningful impact in diabetes care.
  • Help evolve our diabetes management platform to better serve the real-world needs of our users. By sharing their personal insights with our product team, we ensure our platform truly makes a difference.

Inside Look at the Glucose Gladiators’ Mission and Initiatives

Want to hear firsthand about the Glucose Gladiators’ impact? Meet Hadley Horton, a Senior Partner Manager at Glooko and a proud member of our ERG. Having lived with Type 1 diabetes since 2009, Hadley shares how the group’s personal experiences fuel their passion for improving the lives of others in the diabetes community.

MKT-0467

Team Glooko's Ryan H. for Diabetes Awareness Month 2025

Team Glooko for Diabetes Awareness Month 2025Two years ago, my life changed when I was diagnosed with Type 1 diabetes (T1D).

I was 28, and the path to a correct diagnosis was a frustrating battle lasting many months. My primary care doctor initially told me I was “too old” for T1D, so she suspected I potentially had Type 2 diabetes and prescribed basal insulin, metformin, and a BG meter. I initially refused the medication, but began testing my blood glucose. After reaching a level of 650 mg/dL, I accepted the diagnosis and started the medication. It was a turbulent time as I was losing weight and struggling, but I eventually accepted my new reality as a person living with diabetes after my blood work and my first endo appointment.

Today, I’m a completely different person who is now thriving while living with diabetes, fueled by an optimistic outlook and the amazing technology that has made my daily management a total game-changer.

Diabetes Technology Giving Me Control

I honestly don’t have to “think about” my diabetes much anymore, except when I’m eating a carb-heavy meal or exercising. The reason? The powerful diabetes devices I use every day, including:

  • The Dexcom G7 gives me continuous blood sugar readings, which means I no longer have to prick my finger every 20 minutes. That alone is a massive win.
  • The Omnipod 5 is my insulin pump, managing both my basal background and bolus mealtime insulin dosing, essentially acting as an external pancreas.
  • Glooko is my true secret weapon. I love that the mobile app pulls data from my Omnipod, Dexcom G7, and even Apple Health into one place. This makes it incredibly easy for me to track patterns, and it’s an essential tool for my endocrinology team who can review my daily trends and help me fine-tune my care. Knowledge gives you control, and having all my health data centralized is the ultimate power-up.

Passion to Purpose: My Rewarding Journey with Team Glooko

Before I joined Team Glooko, I was already passionate about the diabetes space, staying up to date on new devices and scientific breakthroughs. That’s what drew me to Glooko’s mission to transform diabetes care for healthcare providers and people living with diabetes. Working here has been one of the most rewarding journeys of my life. The community, including the Glucose Gladiators, our employee resource group for people living with diabetes, is highly motivated to make life better for patients and clinicians alike.

It’s a Marathon, Not a Sprint

Team Glooko for Diabetes Awareness Month 2025If I could give some advice to someone newly diagnosed, it would be this: Take it one day at a time and educate yourself. Also, be kind to yourself as it’s okay to have off days. Managing diabetes is a marathon, not a sprint, and you are not alone.

For anyone who doesn’t live with this chronic condition, I want you to know that diabetes feels more like a full-time job than a debilitating disease. Managing blood sugar is a complex, day-to-day process influenced by sleep, stress, exercise, diet, and hormones. It’s a constant juggling act — like a game — where you have to learn from both your wins and your mistakes.

To keep my blood sugar balanced and help make living with diabetes a bit easier on myself, I primarily focus on eating a minimal carb diet with plenty of meat and vegetables. My ultimate go-to meal is sashimi because it’s lean, delicious, and doesn’t require me to bolus insulin. This healthy eating plan works perfectly alongside resistance training and my daily routine, which includes walking my rescue dog, Dude, as the perfect, stress-free way to incorporate consistent, low-impact physical activity.

Major Takeaways on Living with T1D

Team Glooko for Diabetes Awareness Month 2025Looking ahead, while a cure would be incredible, I think advancing diabetes technologies, like making CGMs and insulin pumps even more discreet and reliable, will have a huge impact on quality of life.

Ultimately, I think a lot about the insulin and variety of diabetes technologies we have today that make it possible for me to lead a full, normal life. Not more than a century ago, a diagnosis like mine was essentially a death sentence. I am incredibly grateful to have been diagnosed at a time when insulin therapy is available, technology makes managing my diabetes so streamlined and, thanks to the data Glooko provides, even simpler.

As we recognize Diabetes Awareness Month, I feel really optimistic about the future and the power of data to help endocrinologists improve care even more!

Glooko CEO Mike Alvarez on the acquisition of Monarch Medical Technologies

Glooko CEO Mike AlvarezToday marks an important milestone in our mission to transform diabetes care. I am excited to share that Glooko has acquired Monarch Medical Technologies, creators of the EndoTool® Glucose Management System.

With this acquisition, Glooko is positioned to become the only diabetes management company with the potential to connect the full continuum of care — from home to hospital and back again. By bringing together EndoTool’s proven inpatient insulin dosing technology with Glooko’s leading outpatient platform, we aim to create a future where care is seamless, safer, and more supportive for both people living with diabetes and healthcare providers.

For patients, this means fewer disruptions as they move between settings, reduced risk of dangerous glycemic events, and more confidence that their care is connected. For healthcare providers, it means access to tools that simplify complex insulin management, standardize protocols, and free up time to focus on what matters most, which is caring for people.

This step also sets the foundation for Glooko’s future: using data and AI to help clinicians anticipate risks earlier, personalize care at scale, and improve outcomes under value-based models. By aligning advanced technology with clinical guidelines and EHR workflows, we can help hospitals and health systems deliver higher-quality care while lowering costs.

Our mission has always been clear: to simplify diabetes management, strengthen connections across the care team, and improve lives. This acquisition represents an important stride toward that vision.

Together, we are building a future where diabetes care is more connected, proactive, and patient-centered than ever.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions.

Future of Glooko Diabetes Management

Mark Clements, MD, PhD, Chief Medical and Strategy Officer, Glooko

As healthcare providers, we find ourselves at a pivotal moment in diabetes management. Technological advances — from remote patient monitoring to artificial intelligence — have dramatically reshaped patient care. Yet, amid these innovations, a crucial element often remains overlooked: the voices of clinicians and people with diabetes.

In my new expanded role as Chief Medical and Strategy Officer at Glooko, I am excited about the opportunity to transition from direct patient care into a broader role where I can continue to make a significant impact on diabetes management and improve the lives of people with diabetes. I believe my firsthand clinical experience positions me uniquely to guide Glooko’s innovation efforts, ensuring we build tools that genuinely meet the needs of clinicians and people with diabetes alike.

In my nearly two decades as a pediatric endocrinologist, I’ve observed the profound potential—and the challenges—of integrating digital solutions into daily diabetes management. Clinicians routinely manage a complex array of tasks: reviewing glucose data from continuous glucose monitors (CGMs) or meters, adjusting insulin regimens, coaching patients on lifestyle, documenting clinical decisions, and coordinating across care teams. With a single person’s CGM device generating up to 288 data points per day, 1 clinicians managing numerous people with diabetes face overwhelming workloads.

Individuals with diabetes echo similar concerns. Many describe data fatigue from constant management and analysis of their glucose levels. As one person stated, “The data is overwhelming; without clear insights and simpler ways to interpret it, it’s just noise.”

Although this wealth of data is invaluable, it contributes significantly to clinician burnout, and burn out among people with diabetes. Alarmingly, half to two-thirds of clinicians experience burnout, driven largely by bureaucratic tasks, extended working hours, and the sheer volume of data management.2,3

Glooko CGM for Diabetes

Individuals with diabetes also report significant stress from managing their condition daily. Every glucose reading can feel like a pass or fail test. Effective technological integration could alleviate such emotional burdens by making data actionable, intuitive, and less intrusive.

At Glooko, we recognize that technology alone is not sufficient—it must seamlessly integrate into clinician workflows. Clinicians offer essential insights into behaviors of individuals, adherence barriers, and preferences. Unfortunately, many digital diabetes solutions miss the mark due to inadequate clinician input, leading to underutilization—only about 40% see active clinical use.4 Glooko addresses this by ensuring clinician insights directly shape our technology, streamlining workflow integration through interoperability with electronic health records (EHRs).

In a similar vein, simplicity and intuitive user experiences are paramount for people with diabetes to properly leverage diabetes management technologies. If the technology is complicated, it just becomes another barrier.

Today, our connected care platform exemplifies this integrated approach, merging patient-generated data with clinical decision-making tools. Evidence demonstrates connected care significantly improves diabetes outcomes, with reductions in HbA1c levels of up to 1.5% and fewer hypoglycemic events.5 Glooko enables clinicians to swiftly identify high-risk trends and proactively manage care for people with diabetes.

Tomorrow, AI-driven predictive analytics within Glooko could transform diabetes management by forecasting hypoglycemic and hyperglycemic events, facilitating timely, preventive interventions. Automating routine data analysis tasks can reduce clinicians’ documentation burdens by approximately 30%,6,7 significantly alleviating stress and freeing clinicians to focus more deeply on clinical interactions. For people with diabetes, this can provide a significant improvement in their overall diabetes management.

I believe Glooko has immense potential, especially through advanced analytics and decision support. For instance, we could empower clinicians to shift from generalized treatment plans to highly personalized management strategies, grounded in timely data.

Innovation that is guided by those on the frontlines of care — people with diabetes and their care providers — is critical for meaningful advancements that can truly move the needle in diabetes care. In my role, I am dedicated to ensuring our solutions enhance workflows, support better outcomes, and ultimately bring a human-centric approach to diabetes management.

Together, we will define the future of diabetes care, directly addressing challenges clinicians face and improving the lives of those we treat. Here’s to a bright future ahead!

1. Speakman, ASHP. 2. Hammes et al., Endocrine News; Medscape Endocrinologist Lifestyle Report, 2022. 3. Batta et al., BMJ Open Diabetes Res Care. 4. Shah et al., J. Diabetes Sci Technol., 2023.5. Su et al., J. Med Internet Res., 2023. 6. AMA Digital Health Report. 7. Sidharthan et al., Scientific Reports, 2025.

Glooko's Mike Alvarez

Glooko CEO Mike AlvarezOver the past several months since stepping into the role of CEO at Glooko, I’ve been reflecting on the incredible progress we’ve made, and the immense opportunities that lie ahead. Each day has reaffirmed my belief that our mission to transform diabetes care is both urgent and achievable. I’m more energized than ever to guide Glooko toward a future where we deliver an even greater impact for people with diabetes and those who care for them.

When I think about the future of diabetes care, one word comes to mind: transformation. Across the globe, health systems, clinicians, and people living with diabetes are looking for a holistic approach, one that brings together cutting-edge technology, patient-centric insights, and secure, scalable solutions. At Glooko, we’ve made it our mission to deliver exactly that.

Our Vision: Transforming Diabetes Care

We believe in transforming diabetes care by making it simpler, more connected, and fundamentally centered on people with diabetes. This vision underpins every decision we make, whether we’re enhancing our platform’s EHR integration, partnering with global device manufacturers, or expanding our footprint in new markets.

Our Mission: Simplifying Care and Strengthening Connections

At Glooko, we say: “We simplify care, strengthen connections, and together create a brighter future for people living with diabetes, healthcare providers, and caregivers.”

Simplify Care

We hear time and again about fragmented workflows and siloed data, forcing providers and patients to juggle multiple device platforms (mobile and web), apps, and logins. Our platform intends to change this, meaning clinicians can potentially spend less time on administrative tasks and more time where they’re needed most: caring for patients and focused on improving outcomes.

Strengthen Connections

We also see the power of community and shared decision-making. Through Glooko, patients, caregivers, and healthcare teams can collaborate more effectively, share real-time data, and gain insights that drive meaningful change in care plans. We aim to reduce the cognitive burden of diabetes data and decision making.

In my view, these are the five biggest differentiators that make Glooko stand out:

  1. Patient First Mindset: Everything we do revolves around putting patients first. We collaborate closely with clinicians, caregivers, and people living with diabetes to ensure our technology meets real-world needs.
  2. Commitment to Quality and Security: From ISO 27001 to HiTrust and SOC 2 Type 2 certifications, our platform is backed by enterprise-grade security and rigorously tested reliability. We understand that healthcare data is precious and that trust is earned through quality.
  3. Innovation That Matters: Our platform is more than a “data upload tool.” It’s an engine designed to support clinical decision making. Whether it’s EHR interoperability or automated patient nudges, we constantly push boundaries to develop meaningful solutions that scale globally.
  4. High-Performance Culture: Within the company, we’re building a talented, global team that challenges the status quo. This energy fuels our drive to expand into new markets, partner with industry leaders, and improve access to diabetes care around the world.
  5. Better Together: Collaboration is in our DNA, and that includes partnerships with device manufacturers, healthcare providers and hospital systems. By joining forces with stakeholders across the healthcare ecosystem, we have the opportunity to create value that benefits everyone, especially people living with diabetes.

Scaling for the Future

Our work has already touched millions of lives, but we’re just getting started. With rising rates of diabetes worldwide, the need for an integrated, secure, and human-centered solution has never been greater. That’s why we’re investing in global expansion, forging new alliances, and refining our platform to make sense of the high volume of data in diabetes care.

Scaling effectively also means staying true to our roots. Our commitment to patient outcomes, uncompromising quality, and secure innovation will remain the bedrock of Glooko’s growth. As we continue to expand, our North Star will always be the same: transforming diabetes care on a global scale and making diabetes easier to manage for everyone in the diabetes care ecosystem.

A Commitment to People Living with Diabetes, Above All

Behind every data point or device upload is a person managing a complex, life-altering condition. We never lose sight of that human element. As Glooko grows, our Patients First value continues to guide us toward solutions that truly make a difference, reducing clinical burdens, improving outcomes, and helping people with diabetes live fuller, healthier lives.

MKT-0532 01

Team Glooko

As we continue our celebration of Diabetes Awareness Month, we want to highlight the amazing work being done by the passionate individuals at Glooko who are dedicated to improving the lives of people living with diabetes. Today, we’re excited to share a glimpse into the work of Nele Peters, a key member of our team whose contributions help shape our platform to better support those managing diabetes.

“When I first started at Glooko, I was in contact daily with people living with diabetes. Hearing their stories and feedback made Glooko’s mission feel personal—it became my mission as well. The time I spent speaking directly with users has been incredibly rewarding. Listening to how they use Glooko and how it helps them, fueled my passion for our work,” says Nele. “As Glooko’s Product Specialist, I see how we not only listen to our users but take their stories and feedback seriously, striving to implement their insights into our product to create meaningful improvements.

“I’m incredibly proud to work alongside a team that is so committed to improving the daily experience of people living with diabetes,” says Nele. “What excites me the most is how Glooko doesn’t just provide a product—it fosters a community that listens, learns, and continually strives to do better.”

One of Nele’s favorite features is the upcoming launch of our Glooko Resource Center, which was designed with healthcare providers in mind. This feature allows clinicians to directly access help articles and connect with our customer support team within the Glooko® Web App, streamlining their ability to offer timely support to patients. For Nele, this innovation represents a meaningful step forward in improving the collaboration between healthcare professionals and individuals living with diabetes. “By providing quick access to educational materials and support, clinicians can make the most of their time with patients, ensuring that individuals with diabetes get the guidance they need in real-time.”

Nele is involved in onboarding new team members and introducing them to the vision behind Glooko’s work. One of her favorite parts of the job is sharing the company’s mission with new employees and helping them understand how their role contributes to improving the lives of people managing diabetes.

“There’s something truly special about seeing new team members light up when they realize the impact their work will have on the diabetes community,” Nele says. “It’s a reminder that our work is bigger than just products—we’re making a real difference in people’s lives.”

Nele’s story is a powerful reminder that, through collaboration and continuous improvement, we can make a lasting impact on the lives of those managing diabetes.

MKT-0523 01

Team Glooko

November is Diabetes Awareness Month, a time to reflect on the impact of diabetes on millions of people worldwide and to raise awareness about how we can improve care, outcomes, and quality of life for those living with the condition. At Glooko, we are deeply committed to this mission. Every day, our team works tirelessly to create innovative tools and solutions that empower people with diabetes and their healthcare providers to make informed, life-changing decisions. 

We spoke with key members of our team who are at the forefront of developing these transformative solutions. Their passion, expertise, and personal commitment to improving diabetes care shine through in their work, and we’re excited to share their perspectives on how we’re shaping the future of diabetes management.

Matteo Carli, Senior Director of Product at Glooko, shares our core mission: “Our goal is to bridge the gap between data and actionable care, simplifying diabetes management and enabling more personalized, proactive care.” A key area of passion for Matteo is our Population Health tools, which help healthcare teams proactively identify high-risk patients and deliver preventive care at scale, improving outcomes across communities.

“What motivates me most is the belief that every improvement we make to the Glooko platform brings us closer to empowering people with diabetes and their care teams to achieve healthier, more fulfilling lives,” Matteo adds. “With each step forward, we’re not just refining a tool—we’re shaping a future where diabetes care is more connected, personalized, and transformative for everyone involved.”

For Amanda Martin, Director of Product Design and a person with Type 1 Diabetes, the mission is personal: “I have the privilege of creating solutions that empower people with diabetes and the providers who care for them. As a person with Type 1 Diabetes, I love being part of a team dedicated to making meaningful experiences for patients to improve their care and transform their lives.” Amanda’s unique perspective drives her commitment to designing tools that improve daily diabetes management. “I love how our team brings together passion, empathy, and innovation to create experiences that truly make a difference for those with diabetes.”

This Diabetes Awareness Month, we renew our commitment to reshaping the future of diabetes care—empowering patients, supporting providers, and improving lives.

MKT-0504 01

As I begin my new role as CEO of Glooko, I’m filled with both excitement and a deep sense of responsibility. Diabetes management has always been a deeply personal and complex journey for so many individuals, and the opportunity to lead a company dedicated to easing that burden is truly inspiring. This is more than just a new chapter for me; it’s a chance to make a real difference in the lives of people living with chronic conditions.

With the $100 million Series F financing, Glooko is in a strong position to accelerate our mission—simplifying diabetes management for patients, clinicians, and their care teams. As someone who has spent the majority of my career in healthcare technology and chronic condition management, I’m particularly excited to lead a company that is committed to easing the burden for patients with diabetes and their care teams. I’ve seen firsthand how data—while crucial—can become overwhelming, especially for those managing a condition like diabetes that requires constant monitoring. Whether it’s managing blood glucose levels, using insulin pumps, or trying to make sense of data from multiple apps, patients and clinicians are often left navigating a complex web of information. Particularly for physicians, sifting through and trying to make sense of that same sea of data to provide timely, effective care can be a daunting task.

At Glooko, we’re focused on tackling these challenges head-on. Our platform has the potential to provide actionable insights that streamline the management of chronic diseases like diabetes. We aim to simplify workflows, so that endocrinologists and diabetes care teams can focus on what matters most—to develop early intervention and care pathways that improve patient outcomes. We are also focused on expanding our work with our life sciences partners to enable clinical research and improve outcomes.

Our goal is clear: to make diabetes management easier for everyone—patients, clinicians, and partners. With the recent funding, we’re able to invest further in expanding our platform to support even more customers and to strengthen our integrations with electronic medical records (EMRs). This not only helps clinicians manage their workloads more effectively but also improves care coordination across the board.

I couldn’t be more excited to lead Glooko through this next phase of growth. We are at the forefront of changing how chronic diseases are managed by leveraging data to create new care pathways that make a real difference in patients’ lives. The possibilities for what we can achieve together are limitless, and I’m eager to work with our incredible team to bring these innovations to life.

This moment marks the beginning of an exciting journey, and I’m confident that, together, we’ll continue to set new standards for chronic condition management—making it easier, more efficient, and more effective for all.

Glooko Summer Interns

This summer, we have interns across various functions at Glooko who are working in administrative and technical positions. Through their rewarding roles, they’re making an impact at our digital health company and helping us better our connected care technologies that improve the lives of people with diabetes and related chronic conditions.

Meet our summer interns and hear about their experiences at Glooko.

SUMMER INTERNS

Glooko Summer InternsBased in California, Salvatore Colli, a supply chain major and senior at Rutgers University-New Brunswick, is working on the corporate finance team on projects aligned with sales. He’s using his knowledge to help guide global data and reporting projects around contracts, lead and accounts within Salesforce. He’s found that Glooko has helped prepare him for his future career in a variety of ways, including perfecting multitasking, getting a better grasp of industry software platforms and learning how to better communicate and be organized. His favorite part of interning has been connecting with his colleagues, who are always insightful, professional and have a sense of humor.

Hailing from Connecticut, Jess Innes, a senior at Southern New Hampshire University, is working on our cybersecurity team. Her projects this summer have included audits, policy revisions and security alerts. Through her work, she believes Glooko is helping prepare her for her future career in cybersecurity. She’s found her team to be very enjoyable while working remotely and getting closer to completing her major in cybersecurity.

Jacob Liclican, a recent graduate from University of San Francisco with a major in marketing, joined our human resources team for the summer. He’s working meticulously on maintaining HR Information Systems (HRIS) records and learning more about databases each day. While Glooko has been teaching him the responsibilities and tasks associated within various departments to prepare him for his future career, he’s also had the opportunity to meet many of his colleagues in-person and virtually who he’s found to be very welcoming and supportive.

Tran Nguyen, a Connecticut-based senior at Southern New Hampshire University majoring in information technology, is spending her summer on our IT operations team. During her experience, she has been able to gain working knowledge of various softwares and processes, audits and policy revisions, while managing multiple help desk tickets from employees. She found her tasks this summer to be very interesting and her teammates to be quite helpful.

In our product management department, Lukas Nykaza, a student at Mahomet-Seymour High School in Illinois, is helping document the activation workflows of the recently redesigned Glooko® Mobile App. At our connected care company this summer, he’s learning if product and data management could be a future career. He’s enjoying the flexibility that Glooko provides to their interns and the opportunity to gain knowledge that he will be able to put to future use.

We’re thankful for all the contributions of our interns this summer!

Interested in furthering your career at Glooko? Explore open roles around the world.

MKT-0483 01

Living with Diabetes Team Glooko Phil

In honor of American Diabetes Month, we’re sharing stories of Team Glooko members who are living with diabetes or helping a family member who is impacted by the chronic condition.

On September 11, 2001, Phil Krieg, the global head of customer support and supply chain for Glooko, was diagnosed with type 1 diabetes.

While he’s only been at our connected care company for two years, he had always wanted to work at Glooko and was passionate about joining to further our mission since he’s been a long-time user of our app.

In his role, he works directly with people with diabetes and in many situations, the parents of children with diabetes, to help solve their issues. In these moments, it can be an especially scary time for parents.

“Empathy is key in my position,” said Phil. “I work closely with the users I’m supporting to work through any problems they’re facing as quickly and efficiently as possible.”

Leading the support team from California, he’s able to easily collect and share feedback from customers on the design of Glooko with the product development team, who is always willing to take new ideas and work them into fruition to further enhance the connected care solution.

And as one of the many people on Team Glooko living with diabetes who uses the mobile app on a daily basis, his mission-driven nature goes into the product design as well.

“I’m always looking for ways to improve our app and make it better for users, like myself,” said Phil.

Hear his story.

MKT-0407 03